Cargando…

Rethinking schizophrenia in the context of normal neurodevelopment

The schizophrenia brain is differentiated from the normal brain by subtle changes, with significant overlap in measures between normal and disease states. For the past 25 years, schizophrenia has increasingly been considered a neurodevelopmental disorder. This frame of reference challenges biologica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Catts, Vibeke S., Fung, Samantha J., Long, Leonora E., Joshi, Dipesh, Vercammen, Ans, Allen, Katherine M., Fillman, Stu G., Rothmond, Debora A., Sinclair, Duncan, Tiwari, Yash, Tsai, Shan-Yuan, Weickert, Thomas W., Shannon Weickert, Cynthia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3654207/ https://www.ncbi.nlm.nih.gov/pubmed/23720610 http://dx.doi.org/10.3389/fncel.2013.00060

Ejemplares similares

Speaker 1: Vibeke Catts, Australia
por: Catts, Vibeke S., et al.
Publicado: (2016)

Relationship between somatostatin and death receptor expression in the orbital frontal cortex in schizophrenia: a postmortem brain mRNA study
por: Joshi, Dipesh, et al.
Publicado: (2015)

Testosterone Is Inversely Related to Brain Activity during Emotional Inhibition in Schizophrenia
por: Vercammen, Ans, et al.
Publicado: (2013)

Using blood cytokine measures to define high inflammatory biotype of schizophrenia and schizoaffective disorder
por: Boerrigter, Danny, et al.
Publicado: (2017)

Dysregulation of glucocorticoid receptor co-factors FKBP5, BAG1 and PTGES3 in prefrontal cortex in psychotic illness
por: Sinclair, Duncan, et al.
Publicado: (2013)

Gene Expression Analysis Implicates a Death Receptor Pathway in Schizophrenia Pathology
por: Catts, Vibeke Sørensen, et al.
Publicado: (2012)

Increases in [(3)H]Muscimol and [(3)H]Flumazenil Binding in the Dorsolateral Prefrontal Cortex in Schizophrenia Are Linked to α4 and γ2S mRNA Levels Respectively
por: Verdurand, Mathieu, et al.
Publicado: (2013)

40.1 INFLAMMATORY CYTOKINES ARE ELEVATED IN THE MIDBRAIN IN SCHIZOPHRENIA
por: Purves-Tyson, Tertia, et al.
Publicado: (2018)

Elevated peripheral cytokines characterize a subgroup of people with schizophrenia displaying poor verbal fluency and reduced Broca's area volume
por: Fillman, S G, et al.
Publicado: (2016)

Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder
por: Fillman, S G, et al.
Publicado: (2014)

Developmental Patterns of Doublecortin Expression and White Matter Neuron Density in the Postnatal Primate Prefrontal Cortex and Schizophrenia
por: Fung, Samantha J., et al.
Publicado: (2011)

O11.2. ELEVATION OF MACROPHAGE-RELATED TRANSCRIPTS IN THE MIDBRAIN IN SCHIZOPHRENIA
por: Purves-Tyson, Tertia, et al.
Publicado: (2020)

Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia
por: Catts, Vibeke Sørensen, et al.
Publicado: (2015)

Serotonin Receptor Expression in Human Prefrontal Cortex: Balancing Excitation and Inhibition across Postnatal Development
por: Lambe, Evelyn K., et al.
Publicado: (2011)

Reductions in midbrain GABAergic and dopamine neuron markers are linked in schizophrenia
por: Purves-Tyson, Tertia D., et al.
Publicado: (2021)

Increased macrophages and changed brain endothelial cell gene expression in the frontal cortex of people with schizophrenia displaying inflammation
por: Cai, Helen Q., et al.
Publicado: (2018)

Selective Estrogen Receptor Modulation Increases Hippocampal Activity during Probabilistic Association Learning in Schizophrenia
por: Kindler, Jochen, et al.
Publicado: (2015)

Frontal and Parietal Contributions to Probabilistic Association Learning
por: Rushby, Jacqueline A., et al.
Publicado: (2011)

Developmental changes in human dopamine neurotransmission: cortical receptors and terminators
por: Rothmond, Debora A, et al.
Publicado: (2012)

Brain antibodies in the cortex and blood of people with schizophrenia and controls
por: Glass, L J, et al.
Publicado: (2017)

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
por: Weickert, C S, et al.
Publicado: (2013)

Raloxifene Improves Cognition in Schizophrenia: Spurious Result or Valid Effect?
por: Weickert, Thomas W., et al.
Publicado: (2017)

15. ON THE ROAD TO CURING SCHIZOPHRENIA
por: Weickert, Cynthia Shannon
Publicado: (2018)

Glucocorticoid receptor mRNA and protein isoform alterations in the orbitofrontal cortex in schizophrenia and bipolar disorder
por: Sinclair, Duncan, et al.
Publicado: (2012)

Early Life Stress Alters Expression of Glucocorticoid Stress Response Genes and Trophic Factor Transcripts in the Rodent Basal Ganglia
por: Tran, Cynthia Haidee, et al.
Publicado: (2022)

Cell proliferation is reduced in the hippocampus in schizophrenia
por: Allen, Katherine M, et al.
Publicado: (2015)

Peripheral BDNF: a candidate biomarker of healthy neural activity during learning is disrupted in schizophrenia
por: Skilleter, A. J., et al.
Publicado: (2015)

Glucocorticoid Receptor 1B and 1C mRNA Transcript Alterations in Schizophrenia and Bipolar Disorder, and Their Possible Regulation by GR Gene Variants
por: Sinclair, Duncan, et al.
Publicado: (2012)

Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation
por: Purves-Tyson, Tertia D., et al.
Publicado: (2019)

Cortical grey matter volume reduction in people with schizophrenia is associated with neuro-inflammation
por: Zhang, Y, et al.
Publicado: (2016)

Common polymorphisms in dopamine-related genes combine to produce a ‘schizophrenia-like' prefrontal hypoactivity
por: Vercammen, A, et al.
Publicado: (2014)

Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With Schizophrenia
por: Purves-Tyson, Tertia D., et al.
Publicado: (2020)

Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia
por: Weickert, T W, et al.
Publicado: (2015)

Potential Role of Oestrogen Modulation in the Treatment of Neurocognitive Deficits in Schizophrenia
por: Weickert, Thomas W., et al.
Publicado: (2016)

Increased levels of a pro-inflammatory IgG receptor in the midbrain of people with schizophrenia
por: Petty, A., et al.
Publicado: (2022)

Biomarkers in Schizophrenia: A Brief Conceptual Consideration
por: Weickert, Cynthia S., et al.
Publicado: (2013)

Overexpression of Neuregulin 1 Type III Confers Hippocampal mRNA Alterations and Schizophrenia-Like Behaviors in Mice
por: Olaya, Juan C, et al.
Publicado: (2018)

White matter neuron biology and neuropathology in schizophrenia
por: Duchatel, Ryan J., et al.
Publicado: (2019)

Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrain
por: Purves-Tyson, T D, et al.
Publicado: (2017)

Neuroinflammation in schizophrenia: the role of nuclear factor kappa B
por: Murphy, Caitlin E., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9rmg1jfiu18ijg51fqt085spgn